These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 38576148)
1. Cabtreo: A three-drug gel for acne. Med Lett Drugs Ther; 2024 Apr; 66(1700):59-60. PubMed ID: 38576148 [No Abstract] [Full Text] [Related]
2. Drugs for acne. Med Lett Drugs Ther; 2024 Feb; 66(1695):17-20. PubMed ID: 38294764 [No Abstract] [Full Text] [Related]
3. Tretinoin/benzoyl peroxide cream (Twyneo) for acne. Med Lett Drugs Ther; 2022 May; 64(1650):75-76. PubMed ID: 35536121 [No Abstract] [Full Text] [Related]
4. Clascoterone cream (Winlevi) for acne. Med Lett Drugs Ther; 2021 Dec; 63(1640):202-204. PubMed ID: 35100239 [No Abstract] [Full Text] [Related]
5. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years. Keating GM Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116 [TBL] [Abstract][Full Text] [Related]
6. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study. Gonzalez P; Vila R; Cirigliano M J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047 [TBL] [Abstract][Full Text] [Related]
7. Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris. Tan JK Skin Therapy Lett; 2009; 14(6):4-5. PubMed ID: 19609474 [TBL] [Abstract][Full Text] [Related]
8. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. Del Rosso JQ J Drugs Dermatol; 2007 Jun; 6(6):616-22. PubMed ID: 17668527 [TBL] [Abstract][Full Text] [Related]
9. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study. Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug. Stein Gold L; Baldwin H; Kircik LH; Weiss JS; Pariser DM; Callender V; Lain E; Gold M; Beer K; Draelos Z; Sadick N; Pillai R; Bhatt V; Tanghetti EA Am J Clin Dermatol; 2022 Jan; 23(1):93-104. PubMed ID: 34674160 [TBL] [Abstract][Full Text] [Related]
11. Drugs for acne. Med Lett Drugs Ther; 2020 Nov; 62(1612):188-191. PubMed ID: 33443492 [No Abstract] [Full Text] [Related]
12. Tolerability and irritation potential of four topical acne regimens in healthy subjects. Grove G; Zerweck C; Gwazdauskas J J Drugs Dermatol; 2013 Jun; 12(6):644-9. PubMed ID: 23839180 [TBL] [Abstract][Full Text] [Related]
13. Trifarotene (Aklief) - a new topical retinoid for acne. Med Lett Drugs Ther; 2019 Dec; 61(1587):195-197. PubMed ID: 31999666 [No Abstract] [Full Text] [Related]
14. Letter to the editor: comparative efficacy and safety of clindamycin phosphate/benzoyl peroxide and adapalene/benzoyl peroxide in acne treatment: a systematic review and meta-analysis of randomized controlled trials. Sesgundo JA; Borra UR; Teslim AA; Hikal H; Qammar A; Adams D; Serag I Arch Dermatol Res; 2024 Sep; 316(8):595. PubMed ID: 39225838 [No Abstract] [Full Text] [Related]
15. Application Characteristics and Patient Preference of Triple-Combination vs Layered Topicals for Acne: Split-Face Study. Draelos ZD J Drugs Dermatol; 2024 Oct; 23(10):857-861. PubMed ID: 39361698 [TBL] [Abstract][Full Text] [Related]
16. Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study. Eichenfield LF; Stein Gold L; Kircik LH; Werschler WP; Beer K; Draelos ZD; Tanghetti EA; Papp KA; Baldwin H; Lain E; Sadick N; Gooderham MJ; Konda A Pediatr Dermatol; 2023; 40(3):452-459. PubMed ID: 36949579 [TBL] [Abstract][Full Text] [Related]
17. Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris. Dréno B; Layton AM; Troielli P; Rocha M; Chavda R Eur J Dermatol; 2022 Jul; 32(4):445-450. PubMed ID: 36301750 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of maintenance therapy for acne vulgaris using adapalene 0.1%/benzoyl peroxide 2.5% gel and benzoyl peroxide 2.5% gel for 24 weeks and assessment of atrophic acne scars using three-dimensional image analysis. Tanizaki H; Hayashi N; Abe M J Dermatol; 2023 Dec; 50(12):1513-1522. PubMed ID: 37665181 [TBL] [Abstract][Full Text] [Related]
19. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris. Aschoff R; Möller S; Haase R; Kuske M J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070 [TBL] [Abstract][Full Text] [Related]
20. For Mild to Moderate Acne, Adapalene Plus Benzoyl Peroxide, Clindamycin Plus Benzoyl Peroxide, and Adapalene Alone Are Most Effective. Ebell MH Am Fam Physician; 2022 Jun; 105(6):Online. PubMed ID: 35704803 [No Abstract] [Full Text] [Related] [Next] [New Search]